05/14/2019 /
A round-up of the top epilepsy research news from the past month.
05/14/2019 /
The authors claim that this study supports a mechanism in which loss of potassium SK channel activity causes the reticular thalamic neurons to become hyperexcitable and promote nonconvulsive seizures in Dravet syndrome.
05/14/2019 /
Highly purified cannabidiol (CBD) at a dose of 10mg/kg/day can reduce convulsive seizures in children with Dravet syndrome by almost 50%, a study published in Neurology has found.
05/13/2019 /
SUDEP Action claimed Education Team of the Year at the British Medical Journal (BMJ) Awards 2019.
05/13/2019 /
Recent data suggest that febrile seizures may contribute to sudden unexplained death in childhood (SUDC) among cases of sudden explained death in childhood (SEDC).
05/13/2019 /
Levetiracetam could be considered as an alternative treatment to phenytoin for second-line management of pediatric convulsive status epilepticus.
05/10/2019 /
There are roughly as many autistic boys who have epilepsy as there are girls, according to a new meta-analysis.
05/10/2019 /
Eisai Inc. presented the latest clinical results on FYCOMPA® (perampanel) CIII.
05/10/2019 /
Although the ketogenic diet is the most effective dietary therapy for childhood drug-resistant epilepsy, the modified Atkins diet and low-glycemic index therapy are also effective, better tolerated, and less restrictive.
